AstraZeneca, MMV Collaborate To Develop Anti-Malarial Drugs
As per the terms of the agreement MMV is expected to initially have access to AstraZeneca’s compound library. MMV is also expected to seek to identify compounds that
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).
Forest Labs and Gedeon Richter have evaluated the investigational NR2B-selective NMDA (N-methyl D-aspartate) receptor antagonist, Radiprodil (RGH-896) in the clinical trial for the treatment of neuropathic pain associated